Top

Published in:

01-03-2017 | Letter to the Editors

Folinic acid therapy in cerebral folate deficiency: marked improvement in an adult patient

Authors: Ivan Karin, Ingo Borggraefe, Claudia B. Catarino, Christoph Kuhm, Konstanze Hoertnagel, Saskia Biskup, Thomas Opladen, Nenad Blau, Florian Heinen, Thomas Klopstock

Published in: Journal of Neurology | Issue 3/2017

Excerpt

Dear Sirs, …

Steinfeld R, Grapp M, Kraetzner R et al (2009) Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet 85(3):354–363. doi:10.1016/j.ajhg.2009.08.005 CrossRefPubMedPubMedCentral

Ramaekers V, Sequeira JM, Quadros EV (2013) Clinical recognition and aspects of the cerebral folate deficiency syndromes. Clin Chem Lab Med 51(3):497–511. doi:10.1515/cclm-2012-0543 CrossRefPubMed

Serrano M, Perez-Duenas B, Montoya J et al (2012) Genetic causes of cerebral folate deficiency: clinical, biochemical and therapeutic aspects. Drug Discov Today 17(23–24):1299–1306. doi:10.1016/j.drudis.2012.07.008 CrossRefPubMed

Perez-Duenas B, Ormazabal A, Toma C et al (2011) Cerebral folate deficiency syndromes in childhood: clinical, analytical, and etiologic aspects. Arch Neurol 68(5):615–621. doi:10.1001/archneurol.2011.80 CrossRefPubMed

Steinfeld R (2014) Folate pathway and transport disorders. In: Blau N, Hoffmann GF (eds) Congenital neurotransmitter disorders: a clinical approach. Nova Science Publishers Inc., New York, pp 167–187

Grapp M, Just IA, Linnankivi T et al (2012) Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency. Brain 135(Pt 7):2022–2031. doi:10.1093/brain/aws122 CrossRefPubMed

Weitman S, Lark R, Coney L et al (1992) Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 15 52(12):3396–3401

Verrotti A, Pascarella R, Trotta D et al (2000) Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Res 41(3):253–257CrossRefPubMed

Huemer M, Ausserer B, Graninger G et al (2000) Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation. Epilepsia 46(10):1677–1683. doi:10.1111/j.1528-1167.2005.00264.x CrossRef

10.

Mangold S, Blau N, Opladen T et al (2011) Cerebral folate deficiency: a neurometabolic syndrome? Mol Genet Metab 104(3):369–372. doi:10.1016/j.ymgme.2011.06.004 CrossRefPubMed

11.

Hansen FJ, Blau N (2005) Cerebral folate deficiency: life-changing supplementation with folinic acid. Mol Genet Metab 84(4):371–373. doi:10.1016/j.ymgme.2004.12.001 CrossRefPubMed

12.

Toelle SP, Wille D, Schmitt B et al (2014) Sensory stimulus-sensitive drop attacks and basal ganglia calcification: new findings in a patient with FOLR1 deficiency. Epileptic Disord 16(1):88–92. doi:10.1684/epd.2014.0629 PubMed

13.

Cario H, Bode H, Debatin KM et al (2009) Congenital null mutations of the FOLR1 gene: a progressive neurologic disease and its treatment. Neurology 73(24):2127–2129. doi:10.1212/WNL.0b013e3181c679df CrossRefPubMed

14.

Perez-Duenas B, Toma C, Ormazabal A et al (2010) Progressive ataxia and myoclonic epilepsy in a patient with a homozygous mutation in the FOLR1 gene. J Inherit Metab Dis 33(6):795–802. doi:10.1007/s10545-010-9196-1 CrossRefPubMed

15.

Kobayashi Y, Tohyama J, Akiyama T et al (2016) Severe leukoencephalopathy with cortical involvement and peripheral neuropathy due to FOLR1 deficiency. Brain Dev S0387–7604(16):30160–30167. doi:10.1016/j.braindev.2016.09.011

16.

Delmelle F, Thöny B, Clapuyt P et al (2016) Neurological improvement following intravenous high-dose folinic acid for cerebral folate transporter deficiency caused by FOLR-1 mutation. Eur J Paediatr Neurol 20(5):709–713. doi:10.1016/j.ejpn.2016.05.021 CrossRefPubMed

17.

Dill P, Schneider J, Weber P et al (2011) Pyridoxal phosphate-responsive seizures in a patient with cerebral folate deficiency (CFD) and congenital deafness with labyrinthine aplasia, microtia and microdontia (LAMM). Mol Genet Metab 104(3):362–368. doi:10.1016/j.ymgme.2011.05.019 CrossRefPubMed

18.

Kamen BA, Smith AK (2004) A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev 56(8):1085–1097. doi:10.1016/j.addr.2004.01.002 CrossRefPubMed

Title: Folinic acid therapy in cerebral folate deficiency: marked improvement in an adult patient
Authors: Ivan Karin
Ingo Borggraefe
Claudia B. Catarino
Christoph Kuhm
Konstanze Hoertnagel
Saskia Biskup
Thomas Opladen
Nenad Blau
Florian Heinen
Thomas Klopstock
Publication date: 01-03-2017
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 3/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-016-8387-6

At a glance: The STEP trials

Springer Medicine

Folinic acid therapy in cerebral folate deficiency: marked improvement in an adult patient

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2017

Characterization of the neurological diseases associated with Mycoplasma pneumoniae infection and anti-glycolipid antibodies

MDS clinical diagnostic criteria for Parkinson’s disease in China

Erratum to: Thrombectomy for ischemic stroke: meta-analyses of recurrent strokes, vasospasms, and subarachnoid hemorrhages

Global and regional annual brain volume loss rates in physiological aging

Long term follow-up of cerebrovascular abnormalities in late onset Pompe disease (LOPD)

The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature